Title: Consultant Chief Medical Officer
Company: S McCallum and Associates
Location: Villanova, Pennsylvania, United States
Stewart W McCallum, M.D., FACS, consultant chief medical officer at S McCallum and Associates, has been recognized by Marquis Who’s Who Top Doctors for dedication, achievements, and leadership in health care.
With over two and a half decades of experience to his credit, Mr. McCallum has established a successful career in health care, specializing in pharmaceuticals. He currently excels as the consultant chief medical officer at S McCallum and Associates, a position he has held since 2022. In this role, he provides fractional chief monetary officer support for a range of pharmaceutical technology companies, imaging companies, and laboratory companies to support their clinical development and other needs. His experience also includes chief medical officer at Baudax Bio from 2015 to 2022, senior director at Glaxo Smith Klein from 2006 to 2015, and assistant professor of urology at Stanford University from 1998 to 2006. Throughout his career, he has held a patent for pharmaceutical combinations of beta-3 adrenergic receptor agonists and muscarinic receptor antagonists since 2014 and was honored with teaching awards from Stanford University.
Laying a solid educational foundation, Mr. McCallum earned a Bachelor of Science, with honors, in biochemistry from Western University in 1988, a Doctor of Medicine from the University of Toronto in 1992, and completed an internship in comprehensive surgical at Mount Sinai Hospital in 1993. He then pursued a residency in the department of urology at the University of Toronto in 1997 and a clinical fellowship in the department of urology at Weill Medical College, Cornell University in 1998. He is also a diplomate of The American Board of Urology, a professional organization that certifies urologists in the United States, ensuring they meet high standards of competency, and a fellow of the American College of Surgeons, a professional organization founded in 1913, dedicated to improving surgical patient care and establishing high standards in surgical practice and education.
Reflecting on his path, Dr. McCallum has significantly impacted translational research, focusing on creating new products and techniques to improve patient health, with his work turning innovative ideas into practical solutions. He attributes his success to his relentless drive, perseverance, and grit. For example, during his recent role, he encountered substantial hurdles with FDA approvals, enduring three rounds of reviews and a lengthy process, and despite these challenges, he stayed committed to the end goal. Additionally, when faced with setbacks or rejections, he does not take it personally. Instead, he reflects on what led to the decision and uses it as a learning opportunity to adjust his approach. His background as a urologist does not confine him, rather, he embraces diverse challenges. He believes in offering honest feedback and guidance and helping others navigate obstacles they might not fully recognize or understand.
In the coming years, Dr. McCallum aims to deepen his involvement in translational research and advance innovative trials in human studies, with the ultimate goal of securing approvals. He also hopes to successfully transition their products into the consumer market, making them widely available as treatment options. He is committed to fostering an environment with family, friends, and colleagues that encourages growth, learning, and development, allowing everyone to explore their limits and reach their fullest potential.
For more information, please visit:
Contact Dr. McCallum:
